More News
Want to Read Locked Articles?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Second Shake-up May be Underway in the Glaucoma Pharmaceuticals Market
Author: Peter Downs
Allergan and Novartis replaced Merck and Pfizer at the top of the glaucoma pharmaceuticals market a decade ago. Now it could be their turn to pass the baton. Allergan, acquired by AbbVie in 2020 and now integrated into the company, and Novartis have dominated the glaucoma pharmaceuticals market since 2014, but revenue from their branded glaucoma drugs are falling fast, and so is their market share. The preceding leaders in glaucoma pharmaceuticals climbed to the top of the market around the t...
Purchasing one of the following products will open up access to this article's content, which is also available in each comprehensive report/subscription.
This website uses cookies to ensure you get the best experience. By continuing to use our website, you consent to our use of cookies.